Jason Koon’s Stem Cell Treatment a Success! – PokerTube
|
Jason Koon’s Stem Cell Treatment a Success!
PokerTube Jason Koon’s Stem Cell Treatment a Success! 09:12 13 Feb. It’s not often poker players suffer injuries at the table, but the modern-day emphasis on fitness for those long grinds has certainly seen a few off the tables – the good news for partypoker pro … |
|
Can gene therapy be harnessed to fight the AIDS virus?
ABC News For more than a decade, the strongest AIDS drugs could not fully control Matt Chappell’s HIV infection. Now his body controls it by itself, and researchers are trying to perfect the gene editing that made this possible. Scientists removed some of his … |
|
Can gene therapy be harnessed to fight the AIDS virus?
ABC News For more than a decade, the strongest AIDS drugs could not fully control Matt Chappell’s HIV infection. Now his body controls it by itself, and researchers are trying to perfect the gene editing that made this possible. Scientists removed some of his … |
Business Wire (press release) |
France’s Cellectis wins US patents for gene editing technology
Business Insider “These inventions are based on the early work initiated by inventors at Cellectis when the CRISPR technology first came to light,” the company said. CRISPR, an abbreviation of Clustered Regularly Interspaced Short Palindromic Repeats, forms the basis … Two Issued US Patents Granted to Cellectis for CRISPR Use in T-CellsBusiness Wire (press release) |
Business Wire (press release) |
France’s Cellectis wins US patents for gene editing technology
Channel NewsAsia “These inventions are based on the early work initiated by inventors at Cellectis when the CRISPR technology first came to light,” the company said. CRISPR, an abbreviation of Clustered Regularly Interspaced Short Palindromic Repeats, forms the basis … Two Issued US Patents Granted to Cellectis for CRISPR Use in T-CellsBusiness Wire (press release) |
Business Wire (press release) |
France’s Cellectis wins U.S patents for gene editing technology
Reuters The United States has granted French cell therapy group Cellectis two patents to deploy a technology known as CRISPR in T cells, which play a key role in the immune response to cancer, the company said on Tuesday. Two Issued U.S. Patents Granted to Cellectis for CRISPR Use in T …Business Wire (press release) |